Europes Strategic Posture for Competitive Engagement with China.

Europe faces a systemic rivalry with China, which includes cooperation, competition and confrontation. China challenges European prosperity with unfair trade practices and a dual circulation strategy, affecting the competitiveness of European companies. It uses economic coercion and pressures with trade restrictions. Europe must prepare to counter economic and security threats.
Strengthening local leadership and peer learning to improve education in Nepal.

Strengthening local leadership and peer learning in Nepal can improve education, as the lack of collaboration among municipalities, political rivalry and limited government support hinder the exchange of knowledge and educational innovations. The absence of a culture of sharing perpetuates isolation. Solutions are proposed such as strengthening networks, involving external partners and changing the culture of not sharing knowledge. This could drive collaboration and the exchange of successful experiences.
How the 2025 Protests Are Changing Politics in Asia: A Generation Z Perspective

Generation Z leads protests in Asia, toppling governments in days or evolving into political platforms. In Sri Lanka, Bangladesh, Nepal, Thailand and Indonesia, these movements, influenced by violence and the lack of structured organizations, seek radical and peaceful changes.
Energy in the New Mediterranean Pact: Renewal, Perspectives and Options

The new Mediterranean Pact aims to renew Euro-Mediterranean cooperation, including renewable energy and decarbonization, by promoting investments, networks and integration into fossil-free European chains. The Pact drives collaboration in clean technologies, energy security and socio-economic development. A T-MED Investment Platform is proposed for renewable and hydrogen projects, as well as a regulatory mechanism to support energy reforms in the Mediterranean south.
Potential Savings in the Second Year of the IRA Prescription Drug Negotiation Program.

The IRA Prescription Drug Negotiation Program generated estimated savings of $12 billion in Medicare costs for 15 medications. The Maximum Fair Prices (MFP) applied for 2024 showed expected savings of $12.5 billion, with prices 44% lower than pre-IRA prices. The largest savings come from medications with fewer prior discounts.